Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug Development Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Drug Design
1.2.3 Drug Synthesis
1.2.4 Other
1.3 Market by Application
1.3.1 Global Artificial Intelligence Drug Development Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Tumor
1.3.3 Nervous System
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence Drug Development Market Perspective (2018-2034)
2.2 Artificial Intelligence Drug Development Growth Trends by Region
2.2.1 Global Artificial Intelligence Drug Development Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Artificial Intelligence Drug Development Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence Drug Development Forecasted Market Size by Region (2024-2034)
2.3 Artificial Intelligence Drug Development Market Dynamics
2.3.1 Artificial Intelligence Drug Development Industry Trends
2.3.2 Artificial Intelligence Drug Development Market Drivers
2.3.3 Artificial Intelligence Drug Development Market Challenges
2.3.4 Artificial Intelligence Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence Drug Development Players by Revenue
3.1.1 Global Top Artificial Intelligence Drug Development Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence Drug Development Revenue
3.4 Global Artificial Intelligence Drug Development Market Concentration Ratio
3.4.1 Global Artificial Intelligence Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug Development Revenue in 2024
3.5 Artificial Intelligence Drug Development Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence Drug Development Product Solution and Service
3.7 Date of Enter into Artificial Intelligence Drug Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug Development Breakdown Data by Type
4.1 Global Artificial Intelligence Drug Development Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2024-2034)
5 Artificial Intelligence Drug Development Breakdown Data by Application
5.1 Global Artificial Intelligence Drug Development Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Artificial Intelligence Drug Development Market Size (2018-2034)
6.2 North America Artificial Intelligence Drug Development Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Artificial Intelligence Drug Development Market Size by Country (2018-2023)
6.4 North America Artificial Intelligence Drug Development Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence Drug Development Market Size (2018-2034)
7.2 Europe Artificial Intelligence Drug Development Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Artificial Intelligence Drug Development Market Size by Country (2018-2023)
7.4 Europe Artificial Intelligence Drug Development Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence Drug Development Market Size (2018-2034)
8.2 Asia-Pacific Artificial Intelligence Drug Development Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence Drug Development Market Size (2018-2034)
9.2 Latin America Artificial Intelligence Drug Development Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Artificial Intelligence Drug Development Market Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence Drug Development Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence Drug Development Market Size (2018-2034)
10.2 Middle East & Africa Artificial Intelligence Drug Development Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Detail
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine Artificial Intelligence Drug Development Introduction
11.1.4 Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.1.5 Insilico Medicine Recent Development
11.2 Cyclica
11.2.1 Cyclica Company Detail
11.2.2 Cyclica Business Overview
11.2.3 Cyclica Artificial Intelligence Drug Development Introduction
11.2.4 Cyclica Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.2.5 Cyclica Recent Development
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Detail
11.3.2 XtalPi Inc. Business Overview
11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Introduction
11.3.4 XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.3.5 XtalPi Inc. Recent Development
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Detail
11.4.2 Exscientia Limited Business Overview
11.4.3 Exscientia Limited Artificial Intelligence Drug Development Introduction
11.4.4 Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.4.5 Exscientia Limited Recent Development
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Detail
11.5.2 AiCure, LLC Business Overview
11.5.3 AiCure, LLC Artificial Intelligence Drug Development Introduction
11.5.4 AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.5.5 AiCure, LLC Recent Development
11.6 Atomwise
11.6.1 Atomwise Company Detail
11.6.2 Atomwise Business Overview
11.6.3 Atomwise Artificial Intelligence Drug Development Introduction
11.6.4 Atomwise Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.6.5 Atomwise Recent Development
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Detail
11.7.2 Biovista Inc. Business Overview
11.7.3 Biovista Inc. Artificial Intelligence Drug Development Introduction
11.7.4 Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.7.5 Biovista Inc. Recent Development
11.8 Breg，Inc.
11.8.1 Breg，Inc. Company Detail
11.8.2 Breg，Inc. Business Overview
11.8.3 Breg，Inc. Artificial Intelligence Drug Development Introduction
11.8.4 Breg，Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.8.5 Breg，Inc. Recent Development
11.9 Numerate
11.9.1 Numerate Company Detail
11.9.2 Numerate Business Overview
11.9.3 Numerate Artificial Intelligence Drug Development Introduction
11.9.4 Numerate Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.9.5 Numerate Recent Development
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Detail
11.10.2 Cloud Pharmaceuticals Business Overview
11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Introduction
11.10.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.10.5 Cloud Pharmaceuticals Recent Development
11.11 IBM
11.11.1 IBM Company Detail
11.11.2 IBM Business Overview
11.11.3 IBM Artificial Intelligence Drug Development Introduction
11.11.4 IBM Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.11.5 IBM Recent Development
11.12 NuMedii
11.12.1 NuMedii Company Detail
11.12.2 NuMedii Business Overview
11.12.3 NuMedii Artificial Intelligence Drug Development Introduction
11.12.4 NuMedii Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.12.5 NuMedii Recent Development
11.13 BenevolentAI
11.13.1 BenevolentAI Company Detail
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI Artificial Intelligence Drug Development Introduction
11.13.4 BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.13.5 BenevolentAI Recent Development
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Detail
11.14.2 Lam Therapeutics Business Overview
11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Introduction
11.14.4 Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2018-2023)
11.14.5 Lam Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Artificial Intelligence Drug Development Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Drug Design
Table 3. Key Players of Drug Synthesis
Table 4. Key Players of Other
Table 5. Global Artificial Intelligence Drug Development Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Artificial Intelligence Drug Development Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Artificial Intelligence Drug Development Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Artificial Intelligence Drug Development Market Share by Region (2018-2023)
Table 9. Global Artificial Intelligence Drug Development Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Artificial Intelligence Drug Development Market Share by Region (2024-2034)
Table 11. Artificial Intelligence Drug Development Market Trends
Table 12. Artificial Intelligence Drug Development Market Drivers
Table 13. Artificial Intelligence Drug Development Market Challenges
Table 14. Artificial Intelligence Drug Development Market Restraints
Table 15. Global Artificial Intelligence Drug Development Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Artificial Intelligence Drug Development Market Share by Players (2018-2023)
Table 17. Global Top Artificial Intelligence Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug Development as of 2024)
Table 18. Ranking of Global Top Artificial Intelligence Drug Development Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Artificial Intelligence Drug Development Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Artificial Intelligence Drug Development Product Solution and Service
Table 22. Date of Enter into Artificial Intelligence Drug Development Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Artificial Intelligence Drug Development Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Artificial Intelligence Drug Development Revenue Market Share by Type (2018-2023)
Table 26. Global Artificial Intelligence Drug Development Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Artificial Intelligence Drug Development Revenue Market Share by Type (2024-2034)
Table 28. Global Artificial Intelligence Drug Development Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Artificial Intelligence Drug Development Revenue Market Share by Application (2018-2023)
Table 30. Global Artificial Intelligence Drug Development Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Artificial Intelligence Drug Development Revenue Market Share by Application (2024-2034)
Table 32. North America Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Artificial Intelligence Drug Development Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Artificial Intelligence Drug Development Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Artificial Intelligence Drug Development Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Artificial Intelligence Drug Development Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Artificial Intelligence Drug Development Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Artificial Intelligence Drug Development Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Artificial Intelligence Drug Development Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Artificial Intelligence Drug Development Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Artificial Intelligence Drug Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Artificial Intelligence Drug Development Market Size by Country (2024-2034) & (US$ Million)
Table 47. Insilico Medicine Company Detail
Table 48. Insilico Medicine Business Overview
Table 49. Insilico Medicine Artificial Intelligence Drug Development Product
Table 50. Insilico Medicine Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 51. Insilico Medicine Recent Development
Table 52. Cyclica Company Detail
Table 53. Cyclica Business Overview
Table 54. Cyclica Artificial Intelligence Drug Development Product
Table 55. Cyclica Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 56. Cyclica Recent Development
Table 57. XtalPi Inc. Company Detail
Table 58. XtalPi Inc. Business Overview
Table 59. XtalPi Inc. Artificial Intelligence Drug Development Product
Table 60. XtalPi Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 61. XtalPi Inc. Recent Development
Table 62. Exscientia Limited Company Detail
Table 63. Exscientia Limited Business Overview
Table 64. Exscientia Limited Artificial Intelligence Drug Development Product
Table 65. Exscientia Limited Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 66. Exscientia Limited Recent Development
Table 67. AiCure, LLC Company Detail
Table 68. AiCure, LLC Business Overview
Table 69. AiCure, LLC Artificial Intelligence Drug Development Product
Table 70. AiCure, LLC Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 71. AiCure, LLC Recent Development
Table 72. Atomwise Company Detail
Table 73. Atomwise Business Overview
Table 74. Atomwise Artificial Intelligence Drug Development Product
Table 75. Atomwise Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 76. Atomwise Recent Development
Table 77. Biovista Inc. Company Detail
Table 78. Biovista Inc. Business Overview
Table 79. Biovista Inc. Artificial Intelligence Drug Development Product
Table 80. Biovista Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 81. Biovista Inc. Recent Development
Table 82. Breg，Inc. Company Detail
Table 83. Breg，Inc. Business Overview
Table 84. Breg，Inc. Artificial Intelligence Drug Development Product
Table 85. Breg，Inc. Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 86. Breg，Inc. Recent Development
Table 87. Numerate Company Detail
Table 88. Numerate Business Overview
Table 89. Numerate Artificial Intelligence Drug Development Product
Table 90. Numerate Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 91. Numerate Recent Development
Table 92. Cloud Pharmaceuticals Company Detail
Table 93. Cloud Pharmaceuticals Business Overview
Table 94. Cloud Pharmaceuticals Artificial Intelligence Drug Development Product
Table 95. Cloud Pharmaceuticals Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 96. Cloud Pharmaceuticals Recent Development
Table 97. IBM Company Detail
Table 98. IBM Business Overview
Table 99. IBM Artificial Intelligence Drug Development Product
Table 100. IBM Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 101. IBM Recent Development
Table 102. NuMedii Company Detail
Table 103. NuMedii Business Overview
Table 104. NuMedii Artificial Intelligence Drug Development Product
Table 105. NuMedii Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 106. NuMedii Recent Development
Table 107. BenevolentAI Company Detail
Table 108. BenevolentAI Business Overview
Table 109. BenevolentAI Artificial Intelligence Drug Development Product
Table 110. BenevolentAI Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 111. BenevolentAI Recent Development
Table 112. Lam Therapeutics Company Detail
Table 113. Lam Therapeutics Business Overview
Table 114. Lam Therapeutics Artificial Intelligence Drug Development Product
Table 115. Lam Therapeutics Revenue in Artificial Intelligence Drug Development Business (2018-2023) & (US$ Million)
Table 116. Lam Therapeutics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence Drug Development Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Artificial Intelligence Drug Development Market Share by Type: 2024 VS 2034
Figure 3. Drug Design Features
Figure 4. Drug Synthesis Features
Figure 5. Other Features
Figure 6. Global Artificial Intelligence Drug Development Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 7. Global Artificial Intelligence Drug Development Market Share by Application: 2024 VS 2034
Figure 8. Tumor Case Studies
Figure 9. Nervous System Case Studies
Figure 10. Other Case Studies
Figure 11. Artificial Intelligence Drug Development Report Years Considered
Figure 12. Global Artificial Intelligence Drug Development Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Artificial Intelligence Drug Development Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Artificial Intelligence Drug Development Market Share by Region: 2024 VS 2034
Figure 15. Global Artificial Intelligence Drug Development Market Share by Players in 2024
Figure 16. Global Top Artificial Intelligence Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug Development as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug Development Revenue in 2024
Figure 18. North America Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Artificial Intelligence Drug Development Market Share by Country (2018-2034)
Figure 20. United States Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Artificial Intelligence Drug Development Market Share by Country (2018-2034)
Figure 24. Germany Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Artificial Intelligence Drug Development Market Share by Region (2018-2034)
Figure 32. China Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Artificial Intelligence Drug Development Market Share by Country (2018-2034)
Figure 40. Mexico Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Artificial Intelligence Drug Development Market Share by Country (2018-2034)
Figure 44. Turkey Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Artificial Intelligence Drug Development Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 47. Cyclica Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 48. XtalPi Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 49. Exscientia Limited Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 50. AiCure, LLC Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 51. Atomwise Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 52. Biovista Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 53. Breg，Inc. Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 54. Numerate Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 55. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 56. IBM Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 57. NuMedii Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 58. BenevolentAI Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 59. Lam Therapeutics Revenue Growth Rate in Artificial Intelligence Drug Development Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed